Activity of venetoclax-based therapy in chronic myelomonocytic leukemia

被引：24
|
作者：
Montalban-Bravo, Guillermo [1 ]
Hammond, Danielle [1 ]
DiNardo, Courtney D. [1 ]
Konopleva, Marina [1 ]
Borthakur, Gautam [1 ]
Short, Nicholas J. [1 ]
Ramos-Perez, Jorge [1 ]
Guerra, Veronica [1 ]
Kanagal-Shamanna, Rashmi [2 ]
Naqvi, Kiran [1 ]
Sasaki, Koji [1 ]
Jabbour, Elias [1 ]
Pemmaraju, Naveen [1 ]
Kadia, Tapan M. [1 ]
Ravandi, Farhad [1 ]
Daver, Naval [1 ]
Estrov, Zeev [1 ]
Pierce, Sherry [1 ]
Kantarjian, Hagop [1 ]
Garcia-Manero, Guillermo [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA
来源：
LEUKEMIA | 2021年 / 35卷 / 05期
关键词：
WORLD-HEALTH-ORGANIZATION; MYELOID NEOPLASMS; CLASSIFICATION; REVISION;
D O I：
10.1038/s41375-021-01240-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：1494 / 1499
页数：6
相关论文
共 50 条
  • [1] Activity of venetoclax-based therapy in chronic myelomonocytic leukemia
    Guillermo Montalban-Bravo
    Danielle Hammond
    Courtney D. DiNardo
    Marina Konopleva
    Gautam Borthakur
    Nicholas J. Short
    Jorge Ramos-Perez
    Veronica Guerra
    Rashmi Kanagal-Shamanna
    Kiran Naqvi
    Koji Sasaki
    Elias Jabbour
    Naveen Pemmaraju
    Tapan M. Kadia
    Farhad Ravandi
    Naval Daver
    Zeev Estrov
    Sherry Pierce
    Hagop Kantarjian
    Guillermo Garcia-Manero
    Leukemia, 2021, 35 : 1494 - 1499
  • [2] Outcomes of venetoclax-based therapy in chronic phase and blast transformed chronic myelomonocytic leukemia
    Saliba, Antoine N.
    Litzow, Mark R.
    Gangat, Naseema
    Al-Kali, Aref
    Foran, James M.
    Hogan, William J.
    Palmer, Jeanne M.
    Mangaonkar, Abhishek A.
    Tefferi, Ayalew
    Patnaik, Mrinal M.
    AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (11) : E433 - E436
  • [3] Venetoclax retreatment of patients with chronic lymphocytic leukemia after a previous venetoclax-based regimen
    Thompson, Meghan C.
    Harrup, Rosemary A.
    Coombs, Catherine C.
    Roeker, Lindsey E.
    Pu, Jeffrey J.
    Choi, Michael Y.
    Barr, Paul M.
    Allan, John N.
    Simkovic, Martin
    Leslie, Lori
    Rhodes, Joanna
    Chong, Elise A.
    Kamdar, Manali
    Skarbnik, Alan
    Lansigan, Frederick
    McCall, Brittany
    Saja, Khalid
    Dyer, Martin J. S.
    Walter, Harriet S.
    Lefebure, Marcus
    Thadani-Mulero, Maria
    Boyer, Michelle
    Biondo, Juliana
    Sail, Kavita
    Manzoor, Beenish S.
    Furman, Richard
    Bantilan, Kurt S.
    Goy, Andre
    Feldman, Tatyana
    Labella, Dominic
    Schuster, Stephen J.
    Park, Jae
    Palomba, Lia
    Zelenetz, Andrew
    Eyre, Toby A.
    Kater, Arnon P.
    Seymour, John F.
    Mato, Anthony R.
    BLOOD ADVANCES, 2022, 6 (15) : 4553 - 4557
  • [4] Activity of Venetoclax-Based Therapy in Myelodysplastic Syndrome (MDS)
    Cortes, Jorge
    Garcia-Manero, Guillermo
    Sasaki, Koji
    Naqvi, Kiran
    Alvarado, Yesid
    Kadia, Tapan M.
    Ravandi, Farhad
    Cortes, Jorge E.
    Daver, Naval G.
    Takahashi, Koichi
    Jabbour, Elias
    Borthakur, Gautam M.
    Pemmaraju, Naveen
    Konopleva, Marina Y.
    Pierce, Sherry A.
    Bueso-Ramos, Carlos E.
    Patel, Keyur P.
    Kantarjian, Hagop M.
    Bravo, Guillermo Montalban
    BLOOD, 2019, 134
  • [5] Activity of venetoclax-based therapy in TP53-mutated acute myeloid leukemia.
    Shoukier, Mahran
    Konopleva, Marina
    Dinardo, Courtney Denton
    Ravandi, Farhad
    Andreeff, Michael
    Garcia-Manero, Guillermo
    Jabbour, Elias
    Daver, Naval Guastad
    Borthakur, Gautam
    Pemmaraju, Naveen
    Montalban-Bravo, Guillermo
    Benton, Christopher Brent
    Short, Nicholas James
    Bhalla, Kapil N.
    Cortes, Jorge E.
    Kantarjian, Hagop M.
    Kadia, Tapan M.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [6] Current and emerging investigational venetoclax-based therapies in chronic lymphocytic leukemia
    Molica, Stefano
    Allsup, David
    Gianfelici, Valentina
    Levato, Luciano
    Aiello, Vincenzo
    Bailey, James
    Polliack, Aaron
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2021, 30 (06) : 621 - 633
  • [7] Activity of Venetoclax-Based Therapy in CMML and CMML with Blast Transformation
    Hammond, Danielle
    DiNardo, Courtney D.
    Konopleva, Marina
    Borthakur, Gautam
    Perez, Jorge M. Ramos
    Guerra, Veronica A.
    Kanagal-Shamanna, Rashmi
    Paul, Shilpa
    Naqvi, Kiran
    Sasaki, Koji
    Jabbour, Elias
    Pemmaraju, Naveen
    Kadia, Tapan M.
    Ravandi, Farhad
    Daver, Naval
    Estrov, Zeev E.
    Pierce, Sherry A.
    Kantarjian, Hagop M.
    Garcia-Manero, Guillermo
    Montalban-Bravo, Guillermo
    BLOOD, 2020, 136
  • [8] Venetoclax-based therapies for acute myeloid leukemia
    Guerra, Veronica A.
    DiNardo, Courtney
    Konopleva, Marina
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2019, 32 (02) : 145 - 153
  • [9] Developmental Plasticity of Acute Myeloid Leukemia Mediates Resistance to Venetoclax-Based Therapy
    Pei, Shanshan
    Pollyea, Daniel A.
    Gustafson, Annika
    Minhajuddin, Mohammad
    Stevens, Brett M.
    Ye, Haobin
    Inguva, Anagha
    Amaya, Maria L.
    Krug, Anna
    Jones, Courtney L.
    Adane, Biniam
    Winters, Amanda
    Khan, Nabilah
    Ponder, Jessica
    Schowinsky, Jeffrey
    Hammes, Andrew
    Abbott, Diana
    Myers, Jason R.
    Ashton, John M.
    Gutman, Jonathan A.
    Purev, Enkhtsetseg
    Ramsey, Haley E.
    Savona, Michael R.
    Fesik, Stephen W.
    Smith, Clayton
    Jordan, Craig T.
    BLOOD, 2019, 134
  • [10] Molecular determinants of therapy response of venetoclax-based combinations in acute myeloid leukemia
    Makowka, Philipp
    Stolp, Verena
    Stoschek, Karoline
    Serve, Hubert
    BIOLOGICAL CHEMISTRY, 2021, 402 (12) : 1547 - 1564
12345